A Phase I Study to Evaluate the Pharmacokinetics of MK-7145 Following Single Dose Administration in Patients With Moderate Renal Insufficiency

Trial Profile

A Phase I Study to Evaluate the Pharmacokinetics of MK-7145 Following Single Dose Administration in Patients With Moderate Renal Insufficiency

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 23 Sep 2013

At a glance

  • Drugs MK 7145 (Primary)
  • Indications Hypertension
  • Focus Pharmacokinetics
  • Sponsors Merck & Co
  • Most Recent Events

    • 23 Sep 2013 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 23 May 2013 Planned end date changed from 1 Feb 2014 to 1 Dec 2013 as reported by ClinicalTrials.gov.
    • 23 May 2013 Planned initiation date changed from 1 Sep 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top